SAN DIEGO–(Healthcare Sales & Marketing Network)–Quidel Corporation (NASDAQ: QDEL ), a top provider of rapid diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA)…
Diagnostics, FDA
Quidel, RapidVue, hCG, human Chorionic Gonadotropin, pregnancy test

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Quidel Announces FDA Clearance of Its RapidVue(R) hCG Pregnancy Lateral Flow Diagnostic Test”
Leave a Comment